Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, perioperative enfortumab vedotin plus pembrolizumab improves outcomes for cisplatin-ineligible muscle-invasive bladder cancer patients, based on a phase 3 trial.
Adding durvalumab to chemotherapy before and after surgery improves event-free and overall survival in muscle-invasive bladder cancer, based on the phase 3 NIAGARA trial.
Anemia among pregnant WIC participants increased from 10.1% in 2008 to 11.4% in 2018, with higher rates in Black women and later trimesters.
Immune checkpoint inhibitors appear safe for HBV patients with solid tumors when viral load is suppressed, but reactivation risk exists, especially during immunosuppression for…
Yes, active HBV infection can increase the risk of liver surgery failure, mainly due to higher chances of viral reactivation and liver damage, but antiviral therapy significantly…
Yes, the 15-valent pneumococcal conjugate vaccine (PCV15) is recommended by the CDC for U.S. children aged 6 weeks to 17 years as an option for preventing pneumococcal disease.
Yes, a liver transplant from a donor with HBV can transmit the virus, but the risk is low (about 4%) and can be reduced with antiviral drugs and vaccination.
The 21-valent pneumococcal conjugate vaccine is an approved option for some U.S. adults aged 19 and older who need protection against pneumococcal disease.
The Advisory Committee on Immunization Practices (ACIP) currently recommends the 20-valent pneumococcal conjugate vaccine (PCV20) for children in the United States.
Yes, telitacicept significantly reduces proteinuria in adults with IgA nephropathy, based on a Phase 3 trial and multiple real-world studies.
Yes, specific changes in podocyte shape and structure are linked to higher albumin levels and faster kidney function loss in IgA nephropathy.
Research confirms that pneumococcal vaccines provide protective effects against the disease in children living in sub-Saharan Africa.
Yes, a family history of sudden death independently raises the odds of ventricular fibrillation during a first STEMI by about 60%, according to a large meta-analysis.
Yes, people with myasthenia gravis have an increased risk of developing autoimmune encephalitis, likely due to shared autoimmune mechanisms and overlapping antibody targets.
Yes, complement inhibitors (eculizumab, ravulizumab, zilucoplan) significantly improve symptoms and daily functioning in AChR antibody-positive generalized myasthenia gravis…
Yes, efgartigimod helps improve symptoms in myasthenia gravis patients, with most studies showing clinically meaningful improvements in daily living scores and muscle strength.
Yes, thymoma can be associated with both myasthenia gravis and stiff person syndrome, though this combination is very rare.
Early research suggests a ketogenic diet may improve symptoms and quality of life in myasthenia gravis, but evidence is limited to one small pilot study.
A 12-week nutrition canteen intervention in China significantly reduced body weight and improved inflammatory markers in middle-aged adults.
Yes, a 2024 Cochrane review found no clear evidence that hydrocortisone prevents PTSD after trauma, though some older studies suggested possible benefit.
Yes, intercellular mitochondrial transfers play a key role in inflammation by reprogramming immune cells and promoting pro-inflammatory responses.
Yes, hyperbaric oxygen therapy (HBOT) may improve sleep quality in PTSD patients, based on studies showing significant reductions in sleep disturbance scores.
Obesity fuels kidney inflammation through adipose tissue dysfunction, lipotoxicity, altered secretion of inflammatory factors, and gut-derived uremic toxins, creating a vicious…
Yes, specific assays like whole-genome sequencing developed in Georgia have shown high accuracy for detecting respiratory syncytial virus in clinical specimens.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.